Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap

BACKGROUND: Current guidelines for acute coronary syndrome recommend clopidogrel for an optimal period of 12 months in order to reduce the risk of reinfarction and mortality. Premature clopidogrel discontinuation has been associated with higher rates of rehospitalization, coronary stent thrombosis,...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Page, Robert Lee, Ghushchyan, Vahram, Allen, Richard R, Roper, Lisa, Beck, Don, Jonathan, Bamrom H, Frech-Tamas, Feride, Chan, Wing, McQueen, R Brett, Nair, Kavita V
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2012
Teme:
Short Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3402012/
https://ncbi.nlm.nih.gov/pubmed/22826644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DHPS.S32473
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items